Back to Search
Start Over
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials
- Source :
- EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 8(1)
- Publication Year :
- 2012
-
Abstract
- AIMS The impact of age on outcomes following everolimus-eluting stent (EES) or paclitaxel-eluting stent (PES) implantation was evaluated in a patient-level pooled analysis of the SPIRIT III (n=1,002) and SPIRIT IV (n=3,687) trials. METHODS AND RESULTS Clinical outcomes with EES compared to PES in elderly (≥ 65 years, n=2,071) and younger (
- Subjects :
- Target lesion
Male
medicine.medical_specialty
Time Factors
Paclitaxel
medicine.medical_treatment
Myocardial Infarction
Kaplan-Meier Estimate
Prosthesis Design
Risk Assessment
chemistry.chemical_compound
Risk Factors
Internal medicine
medicine
Humans
Single-Blind Method
Myocardial infarction
Everolimus
Prospective Studies
Angioplasty, Balloon, Coronary
Aged
Sirolimus
business.industry
Age Factors
Stent
Cardiovascular Agents
Drug-Eluting Stents
Thrombosis
Middle Aged
medicine.disease
Surgery
body regions
Clinical trial
Pooled analysis
Logistic Models
Treatment Outcome
chemistry
Multivariate Analysis
Cardiology
Female
Cardiology and Cardiovascular Medicine
business
human activities
Mace
medicine.drug
Subjects
Details
- ISSN :
- 19696213
- Volume :
- 8
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
- Accession number :
- edsair.doi.dedup.....36ec2404beae4a89fd47a7fc700bdbd3